PET/CT Imaging with an 18F-Labeled Galactodendritic Unit in a Galectin-1–Overexpressing Orthotopic Bladder Cancer Model
Open Access
- 31 January 2020
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 61 (9) , 1369-1375
Abstract
Galectins are carbohydrate-binding proteins overexpressed in bladder cancer (BCa) cells. Dendritic galactose moieties have a high affinity for galectin-expressing tumor cells. We radiolabeled a dendritic galactose carbohydrate with 18F (18F-labeled galactodendritic unit 4) and examined its potential in imaging urothelial malignancies. Methods: The 18F-labeled first-generation galactodendritic unit 4 was obtained from its tosylate precursor. We conducted in vivo studies in a galectin-expressing UMUC3 orthotopic BCa model to determine the ability of 18F-labeled galactodendritic unit 4 to image BCa. Results: Intravesical administration of 18F-labeled galactodendritic unit 4 allowed specific accumulation of the carbohydrate radiotracer in galectin-1–overexpressing UMUC3 orthotopic tumors when imaged with PET. The 18F-labeled galactodendritic unit 4 was not found to accumulate in nontumor murine bladders. Conclusion: The 18F-labeled galactodendritic unit 4 and similar analogs may be clinically relevant and exploitable for PET imaging of galectin-1–overexpressing bladder tumors.Keywords
This publication has 24 references indexed in Scilit:
- Promises and challenges of fluorescence cystoscopyUrologic Oncology: Seminars and Original Investigations, 2015
- Galectin-1 Dysregulation Independently Predicts Disease Specific Survival in Bladder Urothelial CarcinomaJournal of Urology, 2015
- Galactodendritic Phthalocyanine Targets Carbohydrate-Binding Proteins Enhancing Photodynamic TherapyPLOS ONE, 2014
- Porphyrin and phthalocyanine glycodendritic conjugates: synthesis, photophysical and photochemical propertiesChemical Communications, 2012
- Real-Time Cancer Cell Tracking by Bioluminescence in a Preclinical Model of Human Bladder Cancer Growth and MetastasisEuropean Urology, 2011
- Galectin-3 expression is associated with bladder cancer progression and clinical outcomeTumor Biology, 2010
- Molecular Pathogenesis and Diagnostics of Bladder CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- Functions of cell surface galectin-glycoprotein latticesCurrent Opinion in Structural Biology, 2007
- Superficial and Muscle-Invasive Bladder Cancer: Principles of Management for Outcomes AssessmentsJournal of Clinical Oncology, 2006
- Molecular imaging of cancer with positron emission tomographyNature Reviews Cancer, 2002